ATE465730T1 - Zusammensetzungen zur steigerung des überlebens von wassertieren, die einem rns-virus ausgesetzt sind - Google Patents

Zusammensetzungen zur steigerung des überlebens von wassertieren, die einem rns-virus ausgesetzt sind

Info

Publication number: ATE465730T1
Authority: AT; Austria
Prior art keywords: infection; survival; bimavirus; aquatic; animals
Prior art date: 2001-12-07

Application number

AT02258455T

Other languages

English (en)

Inventor

Ana Maria Sandino

Geraldine Mlynarz

Original Assignee

Ana Maria Sandino

Geraldine Mlynarz

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-12-07

Filing date

2002-12-09

Publication date

2010-05-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42140308&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE465730(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2002-12-09 Application filed by Ana Maria Sandino, Geraldine Mlynarz filed Critical Ana Maria Sandino

2010-05-15 Application granted granted Critical

2010-05-15 Publication of ATE465730T1 publication Critical patent/ATE465730T1/de

Links

241001465754 Metazoa Species 0.000 title abstract 6
230000004083 survival effect Effects 0.000 title abstract 5
241000700605 Viruses Species 0.000 title abstract 2
239000000203 mixture Substances 0.000 title 1
208000015181 infectious disease Diseases 0.000 abstract 5
238000000034 method Methods 0.000 abstract 4
241000894007 species Species 0.000 abstract 3
241000251468 Actinopterygii Species 0.000 abstract 2
241000702626 Infectious bursal disease virus Species 0.000 abstract 2
241000710921 Infectious pancreatic necrosis virus Species 0.000 abstract 2
AXLOCHLTNQDFFS-BESJYZOMSA-N azastene Chemical class C([C@H]1[C@@H]2CC[C@@]([C@]2(CC[C@@H]1[C@@]1(C)C2)C)(O)C)C=C1C(C)(C)C1=C2C=NO1 AXLOCHLTNQDFFS-BESJYZOMSA-N 0.000 abstract 2
241000287828 Gallus gallus Species 0.000 abstract 1
208000036142 Viral infection Diseases 0.000 abstract 1
235000013330 chicken meat Nutrition 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
244000144977 poultry Species 0.000 abstract 1
235000013594 poultry meat Nutrition 0.000 abstract 1
230000007444 viral RNA synthesis Effects 0.000 abstract 1
230000009385 viral infection Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Epidemiology (AREA)
Virology (AREA)
Molecular Biology (AREA)
General Chemical & Material Sciences (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Farming Of Fish And Shellfish (AREA)
Feed For Specific Animals (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Fodder In General (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

AT02258455T 2001-12-07 2002-12-09 Zusammensetzungen zur steigerung des überlebens von wassertieren, die einem rns-virus ausgesetzt sind ATE465730T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US33668401P	2001-12-07	2001-12-07

Publications (1)

Publication Number	Publication Date
ATE465730T1 true ATE465730T1 (de)	2010-05-15

Family

ID=42140308

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
AT02258455T ATE465730T1 (de)	2001-12-07	2002-12-09	Zusammensetzungen zur steigerung des überlebens von wassertieren, die einem rns-virus ausgesetzt sind
AT10000710T ATE522212T1 (de)	2001-12-07	2002-12-09	Neomycin zur steigerung des überlebens von wassertieren, die einem ipnv ausgesetzt sind

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AT10000710T ATE522212T1 (de)	2001-12-07	2002-12-09	Neomycin zur steigerung des überlebens von wassertieren, die einem ipnv ausgesetzt sind

Country Status (9)

Country	Link
US (2)	US7652050B2 (de)
EP (2)	EP2193792B1 (de)
AT (2)	ATE465730T1 (de)
CA (1)	CA2428703A1 (de)
CL (1)	CL2008003293A1 (de)
DE (1)	DE60236136D1 (de)
DK (2)	DK2193792T3 (de)
ES (2)	ES2345244T3 (de)
NO (2)	NO20025898L (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2006286809B2 (en) *	2005-08-29	2011-07-07	Novartis Tiergesundheit Ag	Use of oxazole derivatives for controlling fish parasites
NO20055541L (no) *	2005-11-23	2007-05-24	Berge Biomed As	Use of fatty acid analogues
CA2801844C (en) *	2010-06-08	2015-08-11	Laboratorio De Diagnostico Gam, S.A.	Use of 1-beta-d-ribofuranosyl-1h-1,2,4-triazole-3-carboxamide for the treatment of infectious salmon anemia
WO2013059168A2 (en) *	2011-10-21	2013-04-25	Research Development Foundation	Espirito santo virus and methods for detecting and preventing infection with the same
KR101540696B1 (ko)	2014-12-12	2015-08-03	대한민국	바이러스 내성 넙치 육종 방법
US20250057849A1 (en) *	2021-12-22	2025-02-20	Cj Cheiljedang Corporation	Antiviral composition comprising nucleoside analogues derived from nucleic acid and pharmaceutically acceptable salt thereof
CN117281905A (zh) *	2023-09-14	2023-12-26	中国水产科学研究院黑龙江水产研究所	磷脂酶a2作为靶点在防治传染性造血器官坏死病毒感染中的应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3878047A (en)	1973-02-02	1975-04-15	Upjohn Co	Process for production of AT-125
US4225720A (en)	1978-05-15	1980-09-30	The Upjohn Company	Purification of AT-125
USRE31578E (en)	1978-05-15	1984-05-01	The Upjohn Company	α(Substituted) amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
US4232164A (en)	1978-05-15	1980-11-04	The Upjohn Company	Purification of AT-125
US4256898A (en)	1978-05-15	1981-03-17	The Upjohn Company	α(substituted) Amino-3-substituted-2-isoxazoline-5-acetic acids (esters)
JPS5793968A (en) *	1980-11-11	1982-06-11	Sankyo Co Ltd	Carbamic acid ester and insecticide containing the same
US4843087A (en)	1983-08-29	1989-06-27	Sterling Drug Inc.	Di-heterocyclic compounds and their use as antiviral agents
US5087639A (en) *	1988-11-02	1992-02-11	The Upjohn Company	Preventing CNS toxicity of acivicin when used with four large neutral amino acids
US5316769A (en)	1989-12-27	1994-05-31	Fujisawa Pharmaceutical Co., Ltd.	Drug for preventing and treating fish diseases
US5349068A (en)	1992-04-15	1994-09-20	Sterling Winthrop Inc.	1,2,4-oxadiazolyl-phenoxyalkylisoxazoles and their use as antiviral agents
US20020058911A1 (en) *	1999-05-07	2002-05-16	Paul Gilson	Support frame for an embolic protection device
US6540722B1 (en) *	1999-12-30	2003-04-01	Advanced Cardiovascular Systems, Inc.	Embolic protection devices
US6689151B2 (en) *	2001-01-25	2004-02-10	Scimed Life Systems, Inc.	Variable wall thickness for delivery sheath housing
WO2003055413A2 (en) *	2001-12-21	2003-07-10	Salviac Limited	A support frame for an embolic protection device
US8182508B2 (en) *	2005-10-04	2012-05-22	Cook Medical Technologies Llc	Embolic protection device
US20070239198A1 (en) *	2006-04-03	2007-10-11	Boston Scientific Scimed, Inc.	Filter and wire with distal isolation

2002
- 2002-12-09 DK DK10000710.3T patent/DK2193792T3/da active
- 2002-12-09 AT AT02258455T patent/ATE465730T1/de not_active IP Right Cessation
- 2002-12-09 ES ES02258455T patent/ES2345244T3/es not_active Expired - Lifetime
- 2002-12-09 NO NO20025898A patent/NO20025898L/no not_active Application Discontinuation
- 2002-12-09 ES ES10000710T patent/ES2372915T3/es not_active Expired - Lifetime
- 2002-12-09 EP EP10000710A patent/EP2193792B1/de not_active Expired - Lifetime
- 2002-12-09 AT AT10000710T patent/ATE522212T1/de not_active IP Right Cessation
- 2002-12-09 DK DK02258455.1T patent/DK1317923T3/da active
- 2002-12-09 US US10/314,366 patent/US7652050B2/en not_active Expired - Fee Related
- 2002-12-09 DE DE60236136T patent/DE60236136D1/de not_active Expired - Lifetime
- 2002-12-09 EP EP02258455A patent/EP1317923B1/de not_active Expired - Lifetime
2003
- 2003-05-14 CA CA002428703A patent/CA2428703A1/en not_active Abandoned
2008
- 2008-11-04 CL CL2008003293A patent/CL2008003293A1/es unknown
2009
- 2009-12-04 US US12/631,543 patent/US8044031B2/en not_active Expired - Fee Related
2011
- 2011-05-03 NO NO20110661A patent/NO335129B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK2193792T3 (da)	2012-01-02
EP1317923A2 (de)	2003-06-11
EP2193792B1 (de)	2011-08-31
CA2428703A1 (en)	2004-11-14
CL2008003293A1 (es)	2009-03-20
US7652050B2 (en)	2010-01-26
EP1317923B1 (de)	2010-04-28
ATE522212T1 (de)	2011-09-15
US20030191169A1 (en)	2003-10-09
DE60236136D1 (de)	2010-06-10
DK1317923T3 (da)	2010-08-09
NO20110661L (no)	2003-06-10
NO20025898L (no)	2003-06-10
NO335129B1 (no)	2014-09-22
ES2372915T3 (es)	2012-01-27
EP2193792A1 (de)	2010-06-09
ES2345244T3 (es)	2010-09-20
NO20025898D0 (no)	2002-12-09
US8044031B2 (en)	2011-10-25
US20100204290A1 (en)	2010-08-12
EP1317923A3 (de)	2003-09-10

Similar Documents

Publication	Publication Date	Title
EA200800209A1 (ru)	2008-06-30	N-тиоантраниламидные соединения и их применение в качестве пестицидов
RU2016129272A (ru)	2018-01-25	Применение изоксазолиновых соединений на домашней птице
DE602004014791D1 (de)	2008-08-14	Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen
EA200500723A1 (ru)	2006-02-24	Соединения бензофурана, композиции и способы лечения и профилактики инфекций, вызванных вирусом гепатита c, и связанных с ним заболеваний
DK1105497T3 (da)	2007-07-30	Koldadapterede hesteinfluenzavira
CL2008003293A1 (es)	2009-03-20	Uso de neomicina para preparar un medicamento para tratar y prevenir una infección causada por un virus birnaviridae en un animal acuatico (div. sol. n°2800-02)
WO2001060849A3 (en)	2002-02-28	Cold-adapted equine influenza viruses
ATE72980T1 (de)	1992-03-15	Anthelmintische quaternaere alkyl-acyl-hydrazone, verfahren zur verwendung und zusammensetzungen.
US7140323B2 (en)	2006-11-28	Reducing the level of bacteria and viruses in aquaculture
ATE77237T1 (de)	1992-07-15	Anthelmintische acylhydrazone, verfahren zur verwendung und zusammensetzungen.
ATE522219T1 (de)	2011-09-15	Zusammensetzungen zur hemmung oder behandlung von hepatitis-c-viren
ATE71839T1 (de)	1992-02-15	Anthelmintische acylhydrazone verfahren zur verwendung und zusammensetzungen.
Roy et al.	2017	Ontogenetic profile of Antiviral Mx gene and its role in innate immunity in Mrigal, Cirrhinus mrigala (Hamilton 1822)
TH92454A (th)	2008-11-28	วัคซีนที่ใช้ทางปาก, วิธีการเตรียมของมันและการใช้วัคซีนเหล่านี้
DE60310975D1 (de)	2007-02-15	Verwendung von epothilone zur behandlung hyperparathyreoidismus
RU2002133057A (ru)	2004-08-10	Способ оральной иммунизации птицы против ньюкаслской болезни
TH69298B (th)	2019-04-10	วิธีสำหรับการกระตุ้นการเติบโตและความต้านทานต่อโรคของสิ่งมีชีวิตในน้ำ
TH109351A (th)	2011-07-22	วิธีสำหรับการกระตุ้นการเติบโตและความต้านทานต่อโรคของสิ่งมีชีวิตในน้ำ
Mao et al.	2012	Immune Response of Turbot to Polyriboinosinic‐polyribocytidilic Acid: the Transcription of Mx, Hepcidin, and IgM
NO20014372D0 (no)	2001-09-07	Isolering og delvis karakterisering av en ny antiprokferativ komponent fra humane leukocytter
TH54057A (th)	2002-11-25	การป้องกันโรคหลอดลมอักเสบในไข่
Voronova et al.	2015	History and Condition Artificial Reproduction of Aquatic Biological Resources in the Fisheries Basin of Baikal
Dzika et al.	2005	Metazoan parasite fauna of fish from the Lake Kortowskie, Poland
RU2007101085A (ru)	2008-07-20	Способ стимуляции иммунной функции организма молодняка крупного рогатого скота мясной породы введением в рацион кормовой добавки "аквакорн"
TH71835A (th)	2005-11-07	สารประกอบใหม่ 2-พิริดินิลเอธิลเบนแซมีด

Legal Events

Date	Code	Title	Description
2010-10-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties